A. Legal Requirement, Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA
Regulation 29A of the Medicines for Human Use (Clinical Trials) Regulations 2004 [Statutory Instrument 2004/1031], as amended by Statutory Instrument 2006/1928, contains a requirement for the notification of “serious breaches” of GCP or the trial protocol:
“29A. (1) The sponsor of a clinical trial shall notify the licensing authority in writing of any serious breach of –
(a) the conditions and principles of GCP in connection with that trial; or
(b) the protocol relating to that trial, as amended from time to time in accordance with regulations 22 to 25, within 7 days of becoming aware of that breach.
(2) For the purposes of this regulation, a “serious breach” is a breach which is likely to effect to a significant degree –
(a) the safety or physical or mental integrity of the subjects of the trial; or
(b) the scientific value of the trial”.
Back to the index of the Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA, Medicines & Healthcare products Regulatory Agency
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
10 – 11 April 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 18 April 2024InformaUnited States
-
17 – 19 April 2024SCDM (Society of Clinical Data Management)Poland
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Bevorstehende klinische Studien
-
Odense University HospitalKarolinska Institutet; Umeå University; Sahlgrenska University Hospital, Sweden; Svendborg Hospital und andere MitarbeiterNoch keine RekrutierungDarmkrebsvorsorgeDänemark
-
Ahmet YuksekRekrutierungEmergenz Agitation | Wiederherstellung der Anästhesie | Bispektraler Index-MonitorTruthahn
-
Assiut UniversityNoch keine RekrutierungArterio-venöse Fistel
-
Anhui Medical UniversityRekrutierungKognitive Beeinträchtigung | Intrakranielle Atherosklerose | Zerebrovaskuläres EreignisChina
-
Methodist Health SystemRekrutierung
-
Heart Rhythm Clinical and Research Solutions, LLCBoston Scientific CorporationNoch keine Rekrutierung
-
IRCCS Fondazione Stella MarisUniversità degli Studi di Trento; Ospedale Borgo Trento - VeronaRekrutierungAutismus-Spektrum-StörungItalien
-
Actym Therapeutics, Inc.Noch keine RekrutierungSolider KrebsAustralien
-
China-Japan Friendship HospitalRekrutierung
-
University of KentuckyDepartment of Health and Human ServicesRekrutierungDiabetes mellitus, Typ 2Vereinigte Staaten
-
AstraZenecaNoch keine RekrutierungHerzkrankheiten | Herz-Kreislauf-Erkrankungen | Herzfehler
-
Sohag UniversityRekrutierungObere gastrointestinale Varizenblutung bei Patienten mit LeberzirrhoseÄgypten